Angion Biomedica Corp
Overview
Angion Biomedica Corp is a biotechnology company focused on developing small molecule therapeutics to address acute and chronic organ injuries, including acute kidney injury and other conditions. The company is committed to discovering and commercializing novel therapies that improve patient outcomes.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Angion Biomedica Corp in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Angion Biomedica Corp?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.